Literature DB >> 26970829

Patient and Facility Variation in Costs of VA Heart Failure Patients.

Jean Yoon1, Gregg C Fonarow2, Peter W Groeneveld3, John R Teerlink4, Mary A Whooley4, Anju Sahay5, Paul A Heidenreich6.   

Abstract

OBJECTIVES: This study sought to determine the variation in annual health care costs among patients with heart failure in the Veterans Affairs (VA) system.
BACKGROUND: Heart failure is associated with considerable use of health care resources, but little is known about patterns in patient characteristics related to higher costs.
METHODS: We obtained VA utilization and cost records for all patients with a diagnosis of heart failure in fiscal year 2010. We compared total VA costs by patient demographic factors, comorbid conditions, and facility where they were treated in bivariate analyses. We regressed total costs on patient factors alone, VA facility alone, and all factors combined to determine the relative contribution of patient factors and facility to explaining cost differences.
RESULTS: There were 117,870 patients with heart failure, and their mean annual VA costs were $30,719 (SD 49,180) with more than one-half of their costs from inpatient care. Patients at younger ages, of Hispanic or black race/ethnicity, diagnosed with comorbid drug use disorders, or who died during the year had the highest costs (all p < 0.01). There was variation in costs by facility as mean adjusted costs ranged from approximately $15,000 to $48,000. In adjusted analyses, patient factors alone explained more of the variation in health care costs (R(2) = 0.116) compared with the facility where the patient was treated (R(2) = 0.018).
CONCLUSIONS: A large variation in costs of heart failure patients was observed across facilities, although this was explained largely by patient factors. Improving the efficiency of VA resource utilization may require increased scrutiny of high-cost patients to determine if adequate value is being delivered to those patients.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  costs; heart failure; veterans

Mesh:

Year:  2016        PMID: 26970829      PMCID: PMC5507550          DOI: 10.1016/j.jchf.2016.01.003

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.544


  30 in total

1.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

2.  Using average cost methods to estimate encounter-level costs for medical-surgical stays in the VA.

Authors:  Todd H Wagner; Shuo Chen; Paul G Barnett
Journal:  Med Care Res Rev       Date:  2003-09       Impact factor: 3.929

3.  Generalized modeling approaches to risk adjustment of skewed outcomes data.

Authors:  Willard G Manning; Anirban Basu; John Mullahy
Journal:  J Health Econ       Date:  2005-05       Impact factor: 3.883

4.  Costs associated with multimorbidity among VA patients.

Authors:  Jean Yoon; Donna Zulman; Jennifer Y Scott; Matthew L Maciejewski
Journal:  Med Care       Date:  2014-03       Impact factor: 2.983

5.  Predictors of costs of caring for elderly patients discharged with heart failure.

Authors:  D J Wexler; J Chen; G L Smith; M J Radford; S Yaari; W D Bradford; H M Krumholz
Journal:  Am Heart J       Date:  2001-08       Impact factor: 4.749

6.  Usefulness of a history of tobacco and alcohol use in predicting multiple heart failure readmissions among veterans.

Authors:  L S Evangelista; L V Doering; K Dracup
Journal:  Am J Cardiol       Date:  2000-12-15       Impact factor: 2.778

7.  Veterans' access to and use of Medicare and Veterans Affairs health care.

Authors:  Denise M Hynes; Kristin Koelling; Kevin Stroupe; Noreen Arnold; Katherine Mallin; Min-Woong Sohn; Frances M Weaver; Larry Manheim; Linda Kok
Journal:  Med Care       Date:  2007-03       Impact factor: 2.983

8.  Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007.

Authors:  Kathleen T Unroe; Melissa A Greiner; Adrian F Hernandez; David J Whellan; Padma Kaul; Kevin A Schulman; Eric D Peterson; Lesley H Curtis
Journal:  Arch Intern Med       Date:  2010-10-11

9.  Psychiatric comorbidity and greater hospitalization risk, longer length of stay, and higher hospitalization costs in older adults with heart failure.

Authors:  Steven L Sayers; Nancy Hanrahan; Ann Kutney; Sean P Clarke; Brendali F Reis; Barbara Riegel
Journal:  J Am Geriatr Soc       Date:  2007-08-21       Impact factor: 5.562

10.  Provider and hospital characteristics associated with geographic variation in the evaluation and management of elderly patients with heart failure.

Authors:  Edward P Havranek; Pam Wolfe; Frederick A Masoudi; Saif S Rathore; Harlan M Krumholz; Diana L Ordin
Journal:  Arch Intern Med       Date:  2004-06-14
View more
  11 in total

1.  A Systematic Review of Direct Cardiovascular Event Costs: An International Perspective.

Authors:  Steve Ryder; Kathleen Fox; Pratik Rane; Nigel Armstrong; Ching-Yun Wei; Sohan Deshpande; Lisa Stirk; Yi Qian; Jos Kleijnen
Journal:  Pharmacoeconomics       Date:  2019-07       Impact factor: 4.981

Review 2.  Economic Issues in Heart Failure in the United States.

Authors:  Paul A Heidenreich; Gregg C Fonarow; Yekaterina Opsha; Alexander T Sandhu; Nancy K Sweitzer; Haider J Warraich
Journal:  J Card Fail       Date:  2022-01-24       Impact factor: 6.592

3.  The Effect of Medicare Accountable Care Organizations on Early and Late Payments for Cardiovascular Disease Episodes.

Authors:  Shashank S Sinha; Nicholas M Moloci; Andrew M Ryan; Adam A Markovitz; Carrie H Colla; Valerie A Lewis; Brent K Hollenbeck; Brahmajee K Nallamothu; John M Hollingsworth
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-08

4.  Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis.

Authors:  Xinchan Jiang; Jiaqi Yao; Joyce Hs You
Journal:  JMIR Mhealth Uhealth       Date:  2020-07-06       Impact factor: 4.773

5.  Quality and Value of Health Care in the Veterans Health Administration: A Qualitative Study.

Authors:  Andrea G Segal; Keri L Rodriguez; Judy A Shea; Kristina L Hruska; Lorrie Walker; Peter W Groeneveld
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501

6.  Association Between Spending and Survival of Chronic Heart Failure Across Veterans Affairs Medical Centers.

Authors:  Peter W Groeneveld; Elina L Medvedeva; Lorrie Walker; Andrea G Segal; Diane M Menno; Andrew J Epstein
Journal:  JAMA Netw Open       Date:  2019-07-03

7.  Healthcare utilization and costs of cardiopulmonary complications following cardiac surgery in the United States.

Authors:  Mitali Stevens; Apeksha V Shenoy; Sibyl H Munson; Halit O Yapici; Boye L A Gricar; Xuan Zhang; Andrew D Shaw
Journal:  PLoS One       Date:  2019-12-19       Impact factor: 3.240

8.  Short and Mid-Term Economic Impact of Pulmonary Artery Catheter Use in Adult Cardiac Surgery: A Hospital and Integrated Health System Perspective.

Authors:  Mitali Stevens; Todd Davis; Sibyl H Munson; Apeksha V Shenoy; Boye L A Gricar; Halit O Yapici; Andrew D Shaw
Journal:  Clinicoecon Outcomes Res       Date:  2021-02-05

9.  Patient and facility variation in costs of catheter ablation for atrial fibrillation.

Authors:  Alexander C Perino; Jun Fan; Susan K Schmitt; Daniel W Kaiser; Paul A Heidenreich; Sanjiv M Narayan; Paul J Wang; Andrew Y Chang; Mintu P Turakhia
Journal:  J Cardiovasc Electrophysiol       Date:  2018-06-22

Review 10.  A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014-2020).

Authors:  Michael Urbich; Gary Globe; Krystallia Pantiri; Marieke Heisen; Craig Bennison; Heidi S Wirtz; Gian Luca Di Tanna
Journal:  Pharmacoeconomics       Date:  2020-11       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.